Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dabigatran etexilate PK/PD study in moderate renal impairment after knee or hip replacement
2010-018723-26Phase 4Completed
- Sponsor
- Boehringer Ingelheim
- Start
- May 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of dabigatran in venous thromboembolism (VTE), sponsored by Boehringer Ingelheim. Primary endpoints: Comparability of dabigatran plasma concentration estimates, Correlation of dabigatran concentration with coagulation parameters and 1 more. Started May 2010; status: completed.
02
Drugs
dabigatran
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on 2010-018723-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-018723-26.